Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Gregory Schwartz

Concepts (589)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
74
2025
295
15.880
 Why?
Anticholesteremic Agents
55
2026
154
12.550
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
57
2025
438
7.720
 Why?
Lipoprotein(a)
22
2025
69
7.410
 Why?
Antibodies, Monoclonal, Humanized
47
2025
990
6.390
 Why?
Cholesterol, LDL
53
2026
359
6.330
 Why?
Myocardial Infarction
45
2026
1209
4.770
 Why?
Cardiovascular Diseases
41
2026
2172
4.360
 Why?
Proprotein Convertase 9
29
2025
87
3.710
 Why?
Coronary Disease
16
2020
381
3.030
 Why?
Angina, Unstable
19
2019
82
2.740
 Why?
Heptanoic Acids
23
2016
67
2.580
 Why?
Cholesterol, HDL
13
2020
199
2.570
 Why?
Diabetes Mellitus, Type 2
23
2025
2573
2.510
 Why?
Dyslipidemias
9
2025
182
2.440
 Why?
Sulfhydryl Compounds
10
2020
188
2.440
 Why?
Hypercholesterolemia
11
2023
93
2.400
 Why?
Pyrroles
23
2016
213
2.370
 Why?
Stroke
32
2026
1262
2.250
 Why?
Quinazolinones
7
2021
19
2.090
 Why?
Serine Proteinase Inhibitors
6
2025
48
2.090
 Why?
Atherosclerosis
12
2026
409
1.590
 Why?
Myocardial Ischemia
17
2018
285
1.560
 Why?
Thiazolidinediones
10
2017
139
1.530
 Why?
Secondary Prevention
11
2019
255
1.520
 Why?
Double-Blind Method
43
2025
2033
1.510
 Why?
Cholesterol
12
2022
404
1.500
 Why?
Treatment Outcome
68
2026
11735
1.420
 Why?
Oxazoles
9
2022
48
1.360
 Why?
Esters
9
2020
72
1.350
 Why?
Amides
9
2020
99
1.320
 Why?
Thiophenes
9
2022
121
1.290
 Why?
Cholesterol Ester Transfer Proteins
5
2016
22
1.270
 Why?
Hypoglycemic Agents
18
2024
1388
1.220
 Why?
Risk Factors
45
2024
10796
1.220
 Why?
Aged
83
2026
25955
1.210
 Why?
Myocardial Contraction
14
2013
288
1.140
 Why?
Middle Aged
87
2026
35971
1.120
 Why?
Ventricular Fibrillation
3
2017
64
1.120
 Why?
Humans
176
2026
144667
1.120
 Why?
Swine
35
2023
828
1.090
 Why?
Coronary Artery Disease
6
2023
743
1.080
 Why?
Risk Assessment
21
2025
3729
1.070
 Why?
C-Reactive Protein
11
2022
420
1.070
 Why?
Insulin Resistance
10
2018
1241
1.060
 Why?
Myocardium
23
2004
928
1.010
 Why?
Antibodies, Monoclonal
7
2023
1505
1.010
 Why?
Diabetic Angiopathies
2
2019
262
0.990
 Why?
Metabolic Syndrome
4
2013
354
0.990
 Why?
Male
110
2026
72431
0.980
 Why?
Female
116
2026
78304
0.920
 Why?
Myocardial Reperfusion Injury
5
2013
139
0.910
 Why?
Ischemic Attack, Transient
6
2018
71
0.890
 Why?
Heart
10
2009
626
0.860
 Why?
PPAR gamma
6
2022
177
0.850
 Why?
Lipoproteins, HDL
4
2019
99
0.850
 Why?
Proteins
3
2020
1016
0.840
 Why?
RNA, Small Interfering
11
2026
631
0.830
 Why?
Hyperlipoproteinemia Type II
4
2026
32
0.820
 Why?
Proprotein Convertases
2
2014
16
0.810
 Why?
Peripheral Arterial Disease
3
2020
504
0.800
 Why?
Triglycerides
5
2024
517
0.770
 Why?
Biomarkers
24
2025
4261
0.770
 Why?
Fatty Acids, Nonesterified
4
2018
154
0.700
 Why?
Renal Insufficiency, Chronic
6
2026
657
0.700
 Why?
Randomized Controlled Trials as Topic
19
2024
1742
0.690
 Why?
Time Factors
22
2025
7140
0.680
 Why?
Patient Admission
2
2021
220
0.660
 Why?
Insulin
7
2021
2502
0.660
 Why?
Coronary Circulation
18
2004
134
0.660
 Why?
Cardiovascular Agents
4
2021
165
0.640
 Why?
Molecular Targeted Therapy
2
2014
437
0.630
 Why?
Hospitalization
5
2019
2446
0.610
 Why?
Recurrence
11
2021
1136
0.600
 Why?
Energy Metabolism
13
2004
927
0.570
 Why?
Adiponectin
2
2018
240
0.550
 Why?
Swine, Miniature
3
2013
89
0.550
 Why?
Lipid Metabolism
2
2014
524
0.530
 Why?
Venous Thrombosis
1
2020
193
0.530
 Why?
Brain Ischemia
5
2022
358
0.530
 Why?
Ezetimibe
4
2023
24
0.520
 Why?
Heart Arrest
4
2017
406
0.520
 Why?
Aldosterone
1
2017
42
0.500
 Why?
Rosuvastatin Calcium
4
2022
21
0.490
 Why?
Cardiovascular System
1
2018
136
0.490
 Why?
Venous Thromboembolism
1
2020
326
0.460
 Why?
Phospholipids
4
2025
214
0.450
 Why?
Arteriosclerosis
2
2014
83
0.440
 Why?
Patient Readmission
2
2021
765
0.430
 Why?
Drug Therapy, Combination
6
2020
1044
0.420
 Why?
Adenosine Triphosphate
14
2017
501
0.410
 Why?
Magnetic Resonance Spectroscopy
17
2019
625
0.390
 Why?
Metformin
1
2017
320
0.390
 Why?
Diabetes Complications
3
2021
223
0.390
 Why?
Apolipoproteins
4
2025
38
0.390
 Why?
Animals
49
2023
37948
0.380
 Why?
Heart Failure
10
2026
2324
0.380
 Why?
Phosphocreatine
13
1995
44
0.370
 Why?
Phosphates
7
2024
177
0.370
 Why?
Ventricular Function, Left
9
2004
536
0.360
 Why?
Veterans
3
2023
1614
0.360
 Why?
Blood Pressure
11
2012
1766
0.360
 Why?
Hemodynamics
11
2007
1113
0.360
 Why?
Proportional Hazards Models
9
2019
1322
0.350
 Why?
Coronary Vessels
8
2012
246
0.350
 Why?
Obesity
3
2024
3070
0.350
 Why?
Uncertainty
1
2012
145
0.340
 Why?
Dietary Fats
2
2013
308
0.340
 Why?
Atrial Fibrillation
2
2022
555
0.330
 Why?
Drug Administration Schedule
8
2019
779
0.330
 Why?
Glucose
5
2020
1033
0.320
 Why?
Follow-Up Studies
11
2023
5414
0.320
 Why?
Systole
7
2001
177
0.320
 Why?
Fluorobenzenes
2
2014
17
0.320
 Why?
Reperfusion Injury
2
2005
296
0.310
 Why?
Research Design
3
2009
1129
0.310
 Why?
Risk
9
2018
911
0.310
 Why?
Phospholipases A2, Secretory
4
2014
14
0.300
 Why?
Diastole
5
2001
142
0.290
 Why?
Ischemia
1
2012
422
0.290
 Why?
Ventricular Dysfunction, Right
3
2007
248
0.280
 Why?
Apolipoproteins B
5
2022
47
0.270
 Why?
Surgical Procedures, Operative
4
2017
272
0.270
 Why?
KATP Channels
1
2008
23
0.270
 Why?
Cohort Studies
6
2023
5957
0.260
 Why?
Clinical Trials, Phase III as Topic
3
2024
116
0.260
 Why?
Chromans
3
2004
23
0.260
 Why?
Acute Disease
9
2012
1029
0.260
 Why?
Peptide Fragments
4
2024
691
0.260
 Why?
Hypolipidemic Agents
3
2022
89
0.260
 Why?
Dose-Response Relationship, Drug
7
2019
2019
0.260
 Why?
Survival Analysis
7
2018
1370
0.250
 Why?
Mortality
3
2017
377
0.250
 Why?
Incidence
7
2022
2892
0.250
 Why?
Veterans Health
2
2020
189
0.250
 Why?
Apolipoprotein B-100
2
2025
13
0.250
 Why?
Potassium
2
2014
152
0.250
 Why?
Sodium
2
2020
198
0.250
 Why?
Cholecalciferol
1
2007
60
0.250
 Why?
Diet
3
2025
1270
0.240
 Why?
Pyrimidines
2
2014
519
0.240
 Why?
Prognosis
6
2024
4312
0.240
 Why?
Sulfonamides
2
2014
579
0.240
 Why?
Subtilisins
2
2023
9
0.230
 Why?
Hyperlipoproteinemia Type III
1
2025
4
0.230
 Why?
Fenofibrate
1
2005
28
0.230
 Why?
Endpoint Determination
1
2026
84
0.230
 Why?
Phenylurea Compounds
1
2026
113
0.230
 Why?
Dobutamine
5
2000
24
0.220
 Why?
Acetates
3
2019
80
0.220
 Why?
Adrenergic beta-Antagonists
3
2013
251
0.220
 Why?
Myelodysplastic Syndromes
1
2007
147
0.220
 Why?
Oxygen Consumption
8
2000
717
0.220
 Why?
Quinolines
1
2026
192
0.220
 Why?
Disease Models, Animal
8
2013
4539
0.220
 Why?
Apolipoprotein A-I
2
2018
39
0.210
 Why?
Cardiotonic Agents
3
2005
94
0.210
 Why?
Blood Glucose
6
2024
2326
0.210
 Why?
Natriuretic Peptide, Brain
3
2024
109
0.210
 Why?
Prediabetic State
2
2020
247
0.210
 Why?
Predictive Value of Tests
6
2025
2117
0.210
 Why?
Lanthanum
1
2024
13
0.210
 Why?
Morbidity
5
2017
322
0.210
 Why?
Hyperemia
3
1991
49
0.210
 Why?
Syndrome
6
2007
379
0.200
 Why?
Cause of Death
5
2017
464
0.200
 Why?
Injections, Subcutaneous
2
2024
168
0.200
 Why?
Phosphorylation
3
2013
1704
0.200
 Why?
Thiazoles
2
2003
139
0.190
 Why?
Isoproterenol
3
1998
96
0.190
 Why?
Serine Endopeptidases
2
2014
129
0.190
 Why?
Blood Vessels
1
2024
167
0.190
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
17
0.190
 Why?
Clinical Trials, Phase II as Topic
2
2019
76
0.190
 Why?
Genes, Bacterial
1
2023
170
0.180
 Why?
Residence Characteristics
3
2016
374
0.180
 Why?
Carcinoma, Hepatocellular
1
2026
370
0.180
 Why?
Lipids
3
2024
706
0.180
 Why?
Calcitriol
2
2003
57
0.180
 Why?
Multicenter Studies as Topic
3
2019
408
0.180
 Why?
Prostatic Neoplasms
5
2003
978
0.180
 Why?
Calcifediol
2
2000
31
0.180
 Why?
Livestock
2
2023
11
0.170
 Why?
Insulin Receptor Substrate Proteins
2
2013
55
0.170
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
204
0.170
 Why?
Diacetyl
1
2001
7
0.170
 Why?
PPAR alpha
4
2022
54
0.170
 Why?
Indoles
3
2019
504
0.170
 Why?
Propensity Score
2
2021
373
0.170
 Why?
Muscles
1
2022
332
0.170
 Why?
Cost-Benefit Analysis
2
2020
638
0.170
 Why?
Artificial Intelligence
1
2026
381
0.170
 Why?
Mental Status and Dementia Tests
1
2021
26
0.160
 Why?
Oxidative Stress
2
2025
1338
0.160
 Why?
Cytokines
2
2005
2045
0.160
 Why?
Pancreatic Neoplasms
2
2000
926
0.160
 Why?
Cataract
1
2023
212
0.160
 Why?
Myocardial Reperfusion
1
2000
57
0.160
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
88
0.150
 Why?
Calpain
2
2012
61
0.150
 Why?
Lipoproteins, LDL
2
2014
119
0.150
 Why?
Coronary Artery Bypass
2
2019
267
0.150
 Why?
Matrix Metalloproteinases
1
2000
95
0.150
 Why?
Cadmium
1
2000
68
0.150
 Why?
Liver Neoplasms
1
2026
777
0.150
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
265
0.150
 Why?
Oncogenes
1
2000
118
0.150
 Why?
Perioperative Care
2
2017
231
0.150
 Why?
Renin-Angiotensin System
1
2019
79
0.140
 Why?
Proto-Oncogene Proteins c-akt
2
2013
435
0.140
 Why?
Aged, 80 and over
9
2026
8284
0.140
 Why?
Alkaline Phosphatase
1
2019
144
0.140
 Why?
Adrenergic beta-Agonists
1
1998
92
0.140
 Why?
Adenylyl Cyclases
2
2016
60
0.140
 Why?
Early Termination of Clinical Trials
2
2015
18
0.140
 Why?
Immunoturbidimetry
1
2018
1
0.140
 Why?
Multifactorial Inheritance
1
2019
190
0.140
 Why?
United States
7
2023
16018
0.140
 Why?
Carotid Artery Diseases
1
2018
70
0.140
 Why?
Risk Reduction Behavior
1
2020
215
0.140
 Why?
Collagen
1
2000
450
0.130
 Why?
American Heart Association
1
2019
356
0.130
 Why?
Environment
2
2016
306
0.130
 Why?
Citrate (si)-Synthase
1
2017
53
0.130
 Why?
Pharmacogenetics
2
2016
172
0.130
 Why?
Prostate
1
1998
158
0.130
 Why?
Transcription Factors
2
2016
1726
0.130
 Why?
Microalgae
1
2016
10
0.130
 Why?
Ponds
1
2016
17
0.130
 Why?
Hypertension, Pulmonary
3
2012
1948
0.120
 Why?
Australia
4
2019
287
0.120
 Why?
Administration, Intravenous
1
2017
170
0.120
 Why?
Waste Disposal, Fluid
1
2016
53
0.120
 Why?
HIV Long Terminal Repeat
1
2016
12
0.120
 Why?
Global Health
2
2017
401
0.120
 Why?
Percutaneous Coronary Intervention
2
2019
547
0.120
 Why?
Drug Design
1
2017
176
0.120
 Why?
tat Gene Products, Human Immunodeficiency Virus
1
2016
25
0.120
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2026
1961
0.120
 Why?
Inflammation Mediators
2
2013
503
0.120
 Why?
Simvastatin
2
2015
59
0.120
 Why?
Lipoproteins
2
2014
165
0.120
 Why?
HIV Envelope Protein gp120
1
2016
55
0.120
 Why?
Adult
15
2026
40489
0.120
 Why?
Signal Transduction
1
2009
5185
0.120
 Why?
Inflammation
6
2016
2870
0.120
 Why?
Epigenesis, Genetic
1
2021
669
0.120
 Why?
AMP-Activated Protein Kinases
1
2017
191
0.110
 Why?
Clinical Trials as Topic
2
2018
1056
0.110
 Why?
Heart Ventricles
6
2012
751
0.110
 Why?
Postoperative Complications
2
2019
2950
0.110
 Why?
Anti-Arrhythmia Agents
2
2012
141
0.110
 Why?
Glomerular Filtration Rate
3
2026
764
0.110
 Why?
ATP Binding Cassette Transporter 1
1
2015
13
0.110
 Why?
Platelet Aggregation Inhibitors
1
2019
496
0.110
 Why?
Recombinant Proteins
1
2018
1363
0.110
 Why?
Vasodilation
2
2013
520
0.110
 Why?
Chromosomes, Human, Pair 16
1
2015
35
0.110
 Why?
Smoking
2
2000
1467
0.110
 Why?
Hospital Mortality
1
2019
1033
0.110
 Why?
Wireless Technology
1
2014
18
0.110
 Why?
Bacteria
2
2023
894
0.110
 Why?
Linkage Disequilibrium
1
2015
249
0.100
 Why?
Homeostasis
1
2018
639
0.100
 Why?
Serum Amyloid A Protein
3
2013
32
0.100
 Why?
Transistors, Electronic
1
2014
7
0.100
 Why?
Stents
1
2018
557
0.100
 Why?
Seawater
1
2014
34
0.100
 Why?
Ions
1
2014
68
0.100
 Why?
Disease Progression
4
2018
2847
0.100
 Why?
Heart Rate
5
2001
853
0.100
 Why?
Fresh Water
1
2014
56
0.100
 Why?
Phospholipases A
1
2014
97
0.100
 Why?
Metals, Heavy
1
2014
32
0.100
 Why?
Fasting
1
2015
275
0.100
 Why?
Mendelian Randomization Analysis
1
2013
54
0.100
 Why?
Endovascular Procedures
1
2018
385
0.100
 Why?
Commerce
1
2014
80
0.100
 Why?
Acyl Coenzyme A
1
2013
32
0.100
 Why?
Heart Function Tests
1
2013
59
0.090
 Why?
Ultraviolet Rays
2
1992
384
0.090
 Why?
Hydroxy Acids
1
2012
4
0.090
 Why?
Ventricular Function, Right
1
1995
296
0.090
 Why?
Monitoring, Physiologic
1
2014
288
0.090
 Why?
Talin
1
2012
9
0.090
 Why?
Ischemic Preconditioning, Myocardial
1
2012
35
0.090
 Why?
Decanoic Acids
1
2012
12
0.090
 Why?
Glyburide
1
2012
31
0.090
 Why?
Cardiolipins
1
2013
83
0.090
 Why?
Nitric Oxide Synthase Type III
1
2013
203
0.090
 Why?
Potassium Channel Blockers
1
2012
47
0.090
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
24
0.090
 Why?
Polymorphism, Genetic
1
2015
613
0.090
 Why?
North America
3
2019
312
0.090
 Why?
Biosensing Techniques
1
2014
140
0.090
 Why?
Case-Control Studies
1
2019
3603
0.090
 Why?
Europe
3
2019
419
0.090
 Why?
Retrospective Studies
6
2018
17149
0.090
 Why?
Keto Acids
3
2019
13
0.090
 Why?
DNA
2
2013
1447
0.080
 Why?
Practice Guidelines as Topic
1
2019
1569
0.080
 Why?
Oxidation-Reduction
4
2025
1078
0.080
 Why?
Hypertension
1
2000
1262
0.080
 Why?
Arteries
1
2013
258
0.080
 Why?
Prospective Studies
2
2021
7994
0.080
 Why?
Tissue Plasminogen Activator
2
2013
244
0.080
 Why?
Genetic Variation
1
2016
985
0.080
 Why?
MAP Kinase Signaling System
1
2013
306
0.080
 Why?
Fractures, Bone
1
2016
417
0.080
 Why?
Manure
2
2023
10
0.080
 Why?
Prejudice
1
2011
61
0.080
 Why?
Myocardial Revascularization
3
2017
84
0.080
 Why?
Death, Sudden, Cardiac
1
2012
230
0.080
 Why?
Electrocardiography
3
2011
664
0.080
 Why?
Phosphorus
5
1995
98
0.080
 Why?
Down-Regulation
2
2024
616
0.080
 Why?
HIV-1
1
2016
897
0.080
 Why?
Gene Expression Regulation
2
2013
2591
0.080
 Why?
United States Department of Veterans Affairs
3
2016
771
0.080
 Why?
Polymers
1
2014
492
0.080
 Why?
RNA, Messenger
3
2015
2815
0.070
 Why?
Age Factors
3
2011
3329
0.070
 Why?
Critical Care
1
2014
695
0.070
 Why?
MicroRNAs
1
2015
689
0.070
 Why?
Macrophages
1
2016
1496
0.070
 Why?
Vitamin D Deficiency
1
1990
187
0.070
 Why?
Vascular Diseases
2
2022
252
0.070
 Why?
Feeding Behavior
1
2014
686
0.070
 Why?
Neoplasms
1
2023
2873
0.070
 Why?
Ventricular Pressure
1
2007
52
0.070
 Why?
Equipment Design
3
2014
527
0.070
 Why?
Diabetes Mellitus
1
2016
1076
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
380
0.060
 Why?
Vitamin D
3
2000
400
0.060
 Why?
Models, Biological
1
2014
1811
0.060
 Why?
Angiomatosis
1
2006
5
0.060
 Why?
Ultrasonography, Interventional
2
2018
161
0.060
 Why?
Hemangioma, Capillary
1
2006
14
0.060
 Why?
Kaplan-Meier Estimate
2
2020
967
0.060
 Why?
Reactive Oxygen Species
1
2009
601
0.060
 Why?
Survival Rate
1
2011
2089
0.060
 Why?
Lactic Acid
2
1998
303
0.060
 Why?
Anti-Inflammatory Agents
1
2009
477
0.060
 Why?
Angina Pectoris
2
2004
75
0.060
 Why?
Ultrasonography
1
2009
776
0.060
 Why?
Apolipoproteins E
1
2025
93
0.060
 Why?
Cerebrovascular Disorders
2
2017
106
0.060
 Why?
Liver
2
2024
1889
0.050
 Why?
Chronic Disease
1
2011
1810
0.050
 Why?
alpha-Tocopherol
1
2004
32
0.050
 Why?
Sus scrofa
1
2004
64
0.050
 Why?
Pulse Wave Analysis
1
2025
266
0.050
 Why?
Linear Models
2
2013
845
0.050
 Why?
Vegetables
1
2025
162
0.050
 Why?
Heterozygote
1
2025
313
0.050
 Why?
Arterial Occlusive Diseases
2
1982
90
0.050
 Why?
Antigen-Antibody Complex
1
2004
70
0.050
 Why?
CD40 Ligand
1
2004
39
0.050
 Why?
Least-Squares Analysis
1
2004
74
0.050
 Why?
Administration, Oral
1
2007
851
0.050
 Why?
Economics, Pharmaceutical
1
2003
10
0.050
 Why?
Muscular Diseases
1
2004
108
0.050
 Why?
Ergocalciferols
1
2003
13
0.050
 Why?
Tumor Cells, Cultured
3
2003
881
0.050
 Why?
Radiation-Sensitizing Agents
1
2003
43
0.050
 Why?
Regional Blood Flow
3
1996
513
0.050
 Why?
Comorbidity
2
2019
1652
0.050
 Why?
Guidelines as Topic
1
2005
267
0.050
 Why?
Lactates
2
1994
83
0.050
 Why?
beta-Lactams
1
2023
32
0.050
 Why?
Death
2
2019
131
0.050
 Why?
Angiotensin Receptor Antagonists
1
2023
115
0.050
 Why?
Creatine Kinase
1
2022
72
0.040
 Why?
Pharmacogenomic Testing
1
2022
62
0.040
 Why?
Multivariate Analysis
2
2017
1537
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2023
228
0.040
 Why?
Drug Resistance, Bacterial
1
2023
205
0.040
 Why?
Verapamil
1
2001
37
0.040
 Why?
Precision Medicine
1
2025
454
0.040
 Why?
Organ Preservation Solutions
1
2001
46
0.040
 Why?
Antioxidants
1
2004
546
0.040
 Why?
Receptors, Immunologic
1
2022
206
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.040
 Why?
Goals
1
2022
184
0.040
 Why?
Ventricular Dysfunction
1
2000
16
0.040
 Why?
Myocardial Stunning
1
2000
4
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
16
0.040
 Why?
Collagenases
1
2000
22
0.040
 Why?
Hexamethonium
1
2000
5
0.040
 Why?
Vascular Stiffness
1
2025
485
0.040
 Why?
Liver Cirrhosis
1
2022
287
0.040
 Why?
Atropine
1
2000
37
0.040
 Why?
Soil Microbiology
1
2023
218
0.040
 Why?
Dilatation, Pathologic
1
2000
61
0.040
 Why?
Arrhythmias, Cardiac
1
2003
355
0.040
 Why?
Louisiana
1
2000
28
0.040
 Why?
Interleukin-6
3
2013
770
0.040
 Why?
Dipeptides
2
2012
56
0.040
 Why?
Health Care Costs
1
2003
425
0.040
 Why?
Cell Line
2
2016
2821
0.040
 Why?
Occupations
1
2000
50
0.040
 Why?
Placebo Effect
1
2019
25
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
130
0.040
 Why?
Pericardium
1
2000
59
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
392
0.040
 Why?
Pilot Projects
1
2025
1886
0.040
 Why?
Blood Chemical Analysis
1
2020
109
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
New Zealand
1
2019
54
0.040
 Why?
Insulin Antagonists
1
1998
6
0.040
 Why?
Ventricular Function
1
1999
54
0.040
 Why?
Logistic Models
1
2004
2114
0.040
 Why?
Antigens, CD
1
2022
552
0.040
 Why?
Hormone Antagonists
1
1998
31
0.040
 Why?
Hungary
1
2018
4
0.040
 Why?
Placebos
1
2019
193
0.040
 Why?
Somatostatin
1
1998
53
0.040
 Why?
Pulmonary Artery
2
2006
1124
0.040
 Why?
Israel
1
2018
46
0.040
 Why?
Infusion Pumps
1
2018
33
0.040
 Why?
Netherlands
1
2018
82
0.040
 Why?
Microscopy, Electron
1
1999
413
0.040
 Why?
India
1
2019
220
0.040
 Why?
Drug Combinations
1
2000
393
0.030
 Why?
Elasticity
1
1999
188
0.030
 Why?
Sex Characteristics
1
2024
776
0.030
 Why?
Florida
1
1998
117
0.030
 Why?
Protective Factors
1
2018
99
0.030
 Why?
Drug Interactions
1
2019
401
0.030
 Why?
Algorithms
1
2026
1844
0.030
 Why?
Sex Factors
1
2024
2104
0.030
 Why?
Blood Flow Velocity
1
1999
419
0.030
 Why?
Drug Industry
1
2017
49
0.030
 Why?
Selection Bias
1
2017
38
0.030
 Why?
Catheterization
1
1997
183
0.030
 Why?
Poverty Areas
1
2016
43
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
195
0.030
 Why?
Echocardiography, Transesophageal
1
1997
132
0.030
 Why?
Chi-Square Distribution
1
2017
524
0.030
 Why?
Urban Health
1
2016
96
0.030
 Why?
Erythrocytes
1
2022
750
0.030
 Why?
Pharmacogenomic Variants
1
2016
33
0.030
 Why?
Rural Health
1
2016
87
0.030
 Why?
Cardiac Catheterization
1
2000
557
0.030
 Why?
Drug Discovery
1
2017
153
0.030
 Why?
Internationality
1
2017
154
0.030
 Why?
Viral Tropism
1
2016
36
0.030
 Why?
Receptors, CCR5
1
2016
60
0.030
 Why?
Albuminuria
1
2017
190
0.030
 Why?
Receptors, CXCR4
1
2016
91
0.030
 Why?
Troponin
2
2007
49
0.030
 Why?
CD4 Antigens
1
2016
137
0.030
 Why?
Immunoglobulin M
2
2009
281
0.030
 Why?
Membrane Proteins
1
2022
1159
0.030
 Why?
Attitude of Health Personnel
1
2004
1180
0.030
 Why?
Fatty Acids
1
1998
454
0.030
 Why?
Genome-Wide Association Study
1
2022
1374
0.030
 Why?
Body Mass Index
1
2024
2419
0.030
 Why?
Myalgia
1
2015
13
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
155
0.030
 Why?
Creatinine
1
2017
509
0.030
 Why?
Physicians
1
2004
949
0.030
 Why?
Receptors, LDL
1
2015
53
0.030
 Why?
Electromagnetic Radiation
1
2014
3
0.030
 Why?
Thrombolytic Therapy
1
1996
161
0.030
 Why?
Cognitive Dysfunction
1
2021
464
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
75
0.030
 Why?
Social Class
1
2016
265
0.030
 Why?
Myositis
1
2015
57
0.030
 Why?
Lidocaine
1
1994
54
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
427
0.030
 Why?
Quality of Life
1
2007
3183
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
122
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
29
0.030
 Why?
Adenosine
2
1994
255
0.030
 Why?
Calibration
1
2014
151
0.030
 Why?
Analysis of Variance
1
2017
1301
0.030
 Why?
Electric Stimulation
1
1995
277
0.030
 Why?
Osmolar Concentration
1
1994
169
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
118
0.030
 Why?
Semiconductors
1
2014
32
0.030
 Why?
Seasons
1
2016
556
0.030
 Why?
Adenosine Diphosphate
1
1994
83
0.030
 Why?
Stroke Volume
1
1997
650
0.030
 Why?
Gene Expression Regulation, Neoplastic
1
2000
1437
0.030
 Why?
Pressure
1
2014
225
0.020
 Why?
Mice
3
2016
18261
0.020
 Why?
NAD
1
1994
82
0.020
 Why?
Solutions
1
2014
166
0.020
 Why?
Patient Outcome Assessment
1
2014
132
0.020
 Why?
Mitochondria, Heart
1
1994
101
0.020
 Why?
Glycine
1
1994
186
0.020
 Why?
Hyperglycemia
1
2017
374
0.020
 Why?
Perioperative Period
1
2013
70
0.020
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
39
0.020
 Why?
Materials Testing
1
2014
348
0.020
 Why?
Binding Sites
1
2016
1307
0.020
 Why?
Heparin
1
1994
243
0.020
 Why?
Oxidative Phosphorylation
1
1994
209
0.020
 Why?
Dose-Response Relationship, Radiation
1
1992
140
0.020
 Why?
Immunoglobulin G
2
2009
886
0.020
 Why?
Nutrition Surveys
1
2014
280
0.020
 Why?
Actinin
1
2012
12
0.020
 Why?
Dogs
3
1984
438
0.020
 Why?
Socioeconomic Factors
1
2016
1322
0.020
 Why?
Anti-Bacterial Agents
1
2023
1928
0.020
 Why?
Weight Gain
1
2016
557
0.020
 Why?
Mathematics
1
1992
100
0.020
 Why?
Cardiomyopathy, Dilated
2
1992
355
0.020
 Why?
Cardiac Output, Low
1
1992
53
0.020
 Why?
South Africa
1
2013
265
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
324
0.020
 Why?
Vascular Resistance
2
1984
368
0.020
 Why?
Patient Selection
1
1996
727
0.020
 Why?
Biopsy
1
1995
1079
0.020
 Why?
Reperfusion
1
1991
54
0.020
 Why?
Perfusion
1
1992
249
0.020
 Why?
Disease-Free Survival
1
2013
768
0.020
 Why?
Georgia
1
2011
79
0.020
 Why?
Poisson Distribution
1
2011
78
0.020
 Why?
Constriction
1
1990
46
0.020
 Why?
Vitamin D-Binding Protein
1
1990
15
0.020
 Why?
Cross-Sectional Studies
2
2014
5870
0.020
 Why?
Anticoagulants
1
1996
729
0.020
 Why?
Cells, Cultured
1
1998
4110
0.020
 Why?
Regression Analysis
1
1992
998
0.020
 Why?
Alleles
1
2013
886
0.020
 Why?
Patient Discharge
1
2017
985
0.020
 Why?
Cell Division
2
2003
753
0.020
 Why?
Cognition Disorders
1
2014
539
0.020
 Why?
Hypoglycemia
1
2015
479
0.020
 Why?
Autoantibodies
2
2009
1505
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
2137
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
92
0.020
 Why?
Educational Status
1
2011
463
0.020
 Why?
Young Adult
2
2016
14122
0.020
 Why?
Thromboembolism
1
2009
126
0.020
 Why?
Environmental Exposure
1
1992
574
0.020
 Why?
Spectrin
1
2007
14
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Densitometry
1
2007
35
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
32
0.020
 Why?
Databases, Factual
1
2013
1494
0.020
 Why?
Poverty
1
2011
522
0.020
 Why?
Heart Diseases
1
1990
341
0.020
 Why?
Calcium-Binding Proteins
1
2007
222
0.010
 Why?
Kidney
1
2014
1495
0.010
 Why?
ROC Curve
1
2007
618
0.010
 Why?
Fatal Outcome
1
2006
305
0.010
 Why?
Protein Processing, Post-Translational
1
2007
466
0.010
 Why?
Aminophylline
1
1984
12
0.010
 Why?
Vasomotor System
1
1984
46
0.010
 Why?
Solubility
1
2004
236
0.010
 Why?
Mice, Inbred C57BL
1
2014
5967
0.010
 Why?
Radiation, Ionizing
1
2003
86
0.010
 Why?
DNA, Neoplasm
1
2003
158
0.010
 Why?
Health Care Surveys
1
2004
537
0.010
 Why?
Immunohistochemistry
1
2006
1705
0.010
 Why?
Odds Ratio
1
2004
1076
0.010
 Why?
Electrophysiology
1
1982
218
0.010
 Why?
Echocardiography
2
1997
644
0.010
 Why?
Blotting, Western
1
2003
1161
0.010
 Why?
Vascular Surgical Procedures
1
2004
343
0.010
 Why?
Mixed Function Oxygenases
1
2000
49
0.010
 Why?
Chemoprevention
1
2000
91
0.010
 Why?
Hydrogen-Ion Concentration
2
1991
562
0.010
 Why?
Adolescent
2
2016
22409
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2000
973
0.010
 Why?
Thorax
1
1997
51
0.010
 Why?
Phosphorus Isotopes
1
1995
8
0.010
 Why?
Infusions, Parenteral
1
1994
47
0.010
 Why?
Apoptosis
1
2003
2397
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
84
0.010
 Why?
Basal Metabolism
1
1994
59
0.010
 Why?
Substrate Specificity
1
1995
392
0.010
 Why?
T-Lymphocytes
1
2002
1984
0.010
 Why?
Glycolysis
1
1995
341
0.010
 Why?
Lung
1
2006
4089
0.010
 Why?
Stimulation, Chemical
1
1992
52
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2521
0.010
 Why?
Diphosphoglyceric Acids
1
1991
3
0.010
 Why?
2,3-Diphosphoglycerate
1
1991
32
0.010
 Why?
Radio Waves
1
1991
28
0.010
 Why?
Rats
1
1997
5570
0.000
 Why?
Cardiomegaly
1
1990
174
0.000
 Why?
Theophylline
1
1984
41
0.000
 Why?
Heart Block
1
1984
40
0.000
 Why?
Oxygen
1
1984
984
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3888
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (589) concept(s)
_
Co-Authors Expand Description
See all (25) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)